2BKT
crystal structure of renin-pf00257567 complex
Summary for 2BKT
Entry DOI | 10.2210/pdb2bkt/pdb |
Related | 1BBS 1BIL 1BIM 1HRN 1PR7 1PR8 1RNE 1UHQ 2BKS 2REN |
Descriptor | RENIN, 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]-PHENYL}-6-(1,2,,3,4-TETRAHYDRO-QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN-2-ONE (3 entities in total) |
Functional Keywords | renin, aspartyl protease, hydrolase |
Biological source | HOMO SAPIENS |
Cellular location | Secreted: P00797 |
Total number of polymer chains | 2 |
Total formula weight | 75597.30 |
Authors | Powell, N.A.,Clay, E.H.,Holsworth, D.D.,Edmunds, J.J.,Bryant, J.W.,Ryan, J.M.,Jalaie, M.,Zhang, E. (deposition date: 2005-02-18, release date: 2006-04-05, Last modification date: 2011-07-13) |
Primary citation | Powell, N.A.,Clay, E.H.,Holsworth, D.D.,Bryant, J.W.,Ryan, J.M.,Jalaie, M.,Zhang, E.,Edmunds, J.J. Equipotent Activity in Both Enantiomers of a Series of Ketopiperazine-Based Renin Inhibitors Bioorg.Med.Chem.Lett., 15:2371-, 2005 Cited by PubMed Abstract: We have found that both enantiomeric configurations of the 6-alkoxymethyl-1-aryl-2-piperazinone scaffold display equipotent renin inhibition activity and similar SAR patterns. This enantiomeric flexibility is in contrast to a previously reported 3-alkoxymethyl-4-arylpiperidine scaffold. PubMed: 15837327DOI: 10.1016/J.BMCL.2005.02.085 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report